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Defects in mitochondrial OXPHOS are associated
with diverse and mostly intractable human disorders.
The single-subunit alternative oxidase (AOX) found in
many eukaryotes, but not in arthropods or verte-
brates, offers a potential bypass of the OXPHOS
cytochrome chain under conditions of pathological
OXPHOS inhibition. We have engineeredCiona intes-
tinalis AOX for conditional expression in Drosophila
melanogaster.Ubiquitous AOX expression produced
no detrimental phenotype in wild-type flies. How-
ever, mitochondrial suspensions from AOX-express-
ing flies exhibited a significant cyanide-resistant
substrate oxidation, and the flies were partially
resistant to both cyanide and antimycin. AOX
expression was able to complement the semilethality
of partial knockdown of both cyclope (COXVIc) and
the complex IV assembly factorSurf1. It also rescued
the locomotor defect and excess mitochondrial ROS
production of flies mutated in dj-1b, a Drosophila
homolog of the human Parkinson’s disease gene
DJ1. AOX appears to offer promise as a wide-spec-
trum therapeutic tool in OXPHOS disorders.
INTRODUCTION
Dysfunction of the mitochondrial oxidative phosphorylation
(OXPHOS) system is a recognized feature of many disease
states. These range from the classical mitochondrial encephalo-
myopathies, both pediatric (Moslemi and Darin, 2007) and adult-
onset (Finsterer, 2004), to cases of common multifactorial disor-
ders such as diabetes (Maassen et al., 2004; Kim et al., 2008) and
deafness (Kokotas et al., 2007). In addition, many late-onset
neurodegenerative disorders, such as Parkinson’s disease, are
associated with OXPHOS dysfunction, which has been postu-lated as instrumental in pathogenesis (Dimauro and Schon,
2008; Reeve et al., 2008). Mostly these disorders are progressive
and incurable.
The OXPHOS system (Smeitink et al., 2001) comprises the five
multisubunit complexes involved in respiratory electron flow and
ATP synthesis, plus the entire apparatus for their biosynthesis.
This includes the machinery of mtDNA maintenance and gene
expression, four of the OXPHOS complexes (I, III, IV, and V) con-
taining mtDNA-encoded subunits. Complex II, plus several other
non-proton-pumping dehydrogenases, feed electrons directly
into the downstream (cytochrome) portion of the respiratory
chain, complexes III and IV.
OXPHOS disease can result from deficiency or dysfunction of
any component of this system. Genetic targets include both
structural subunits of the OXPHOS complexes, plus those
involved in biosynthesis and assembly (Smeitink et al., 2001):
in total, over 200 different gene products. OXPHOS inhibition
can also result from the action of toxins that target specific enzy-
matic steps, such as complexes I (rotenone), III (antimycin), IV
(cyanide), or V (oligomycin).
OXPHOS dysfunction entrains a range of metabolic distur-
bances in addition to bioenergy deficit, and these may underlie
much of the pathology of OXPHOS disease (Smeitink et al.,
2006). Inhibition of electron flow can result in the excess produc-
tion of reactive oxygen species (ROS) at complexes I and/or III if
the quinone pool becomes overreduced. Excessive ROS
production can damage lipids, proteins, carbohydrates, and nu-
cleic acids, and if such damage is not repaired, it can result in cell
death. The need to recruit cytosolic shunts for the reoxidation of
NADH, notably lactate dehydrogenase, results in the production
of lactic acid, which leads to cellular and systemic acidosis.
Finally, limitations on NADH reoxidation as well as on substrate
flux may result in a more general impairment of metabolism,
including deficiency of carbon skeletons for biosynthesis and
deranged calcium homeostasis.
Most eukaryotes possess an alternativemitochondrial respira-
tory chain, which can bypass the OXPHOS system under
specific physiological conditions. Plants, in particular, typicallyCell Metabolism 9, 449–460, May 6, 2009 ª2009 Elsevier Inc. 449
Cell Metabolism
AOX Expression Complements OXPHOS Defects in FliesFigure 1. Scheme for AOX Expression in Drosophila
(A) Schematic map of transgenic construct pUAS-AOX-H-Pelican. For construction details, see Figure S1. The 30 and 50 P-element ends (P30, P50, black) flank the
two coding regions, i.e., of the selectable eye-color marker w+ (light gray) under its own promoter and AOX under the control of the GAL4-dependent 53UAS
element (cross-hatched) combined with the (reiterated) weak basal promoter of the Hsp70 gene (block arrow). The AOX expression cassette is flanked by gypsy
insulator elements (ins, dark gray).
(B) Crossing scheme to obtain AOX-expressing progeny. Transgenic hemizygotes (AOX transgene on chromosome 2, carrying the mini-white w+ eye-color
marker; 2 denotes wild-type chromosome 2) were crossed to hemizygotes for the ubiquitous da-GAL4 driver (on chromosome 3, balanced against theSbmarker;
3 denotes wild-type chromosome 3). All flies were in thew1118 genetic background. Different progeny classes were identified on the basis of eye-color and bristle
morphology phenotypes. Nontransgenic, nonexpresser, and ‘‘driver-only’’ progeny represent controls for the various experiments. An analogous strategy was
used for transgenes on chromosome 3, using the ubiquitous Act5C-GAL4 driver on chromosome 2 balanced againstCyO. For all AOX transgenic lines tested, the
four progeny classes eclosed in approximately equal numbers.Where not indicated in subsequent figures, AOX expressers and nonexpressers were derived from
AOX transgenic line F6 using this crossing scheme.have several NADH dehydrogenases that bypass complex I
(Rasmusson et al., 2004), plus a mitochondrially localized alter-
native oxidase (AOX), which bypasses the cytochrome chain,
passing electrons directly from ubiquinol to molecular oxygen
(Juszczuk and Rychter, 2003). AOX is an integral nonheme iron
protein of the inner mitochondrial membrane, believed to func-
tion as a homodimer. It is thought to be essential for maintaining
mitochondrial metabolic flux and redox homeostasis when ATP
levels are high, such as in plants under daylight conditions (Rus-
tin and Lance, 1986; Noguchi and Yoshida, 2008). In fungi, AOX
has been implicated in the control of longevity and resistance to
oxidative stress (Lorin et al., 2001). AOX is also found in many
metazoans, including annelids, mollusks, and urochordates
(McDonald and Vanlerberghe, 2004, 2006), although not in
arthropods or vertebrates, and it has been suggested to provide
resistance to oxidative stress (Abele et al., 2007).
We reasoned that an AOX bypass might alleviate many of the
pathological consequences of OXPHOS inhibition. Since AOX is
absent from humans, we tested this idea by introducing to
human cells an AOX cDNA from the urochordateCiona intestina-
lis, i.e., a representative of a sister taxon to the vertebrates. Using
an inducible expression system, we demonstrated (Hakkaart
et al., 2006) that Ciona AOX is mitochondrially targeted in human
cells, confers cyanide-resistant respiration, and protects against
metabolic acidosis, oxidative stress, and cell death when cells
are treated with OXPHOS inhibitors such as antimycin or
cyanide.
Here, we tested whether AOX expression can be tolerated in
the whole organism and whether it can alleviate the effects of
OXPHOS dysfunction in vivo using Drosophila, a credible and
tractable animal model for many mitochondrial and neurodegen-
erative pathologies (Sa´nchez-Martı´nez et al., 2006; Marsh and
Thompson, 2006). We report that ubiquitous expression ofCiona
AOX in the fly is benign, enabling cyanide-resistant substrate450 Cell Metabolism 9, 449–460, May 6, 2009 ª2009 Elsevier Inc.oxidation in vitro and a substantial resistance to OXPHOS toxins
in vivo. In addition, AOX partially compensated the mutant
phenotypes of several disease-equivalent mutations.
RESULTS
AOX-Expressing Flies Are Viable and Healthy
To create lines ofDrosophila transgenic for AOX, we recloned the
Ciona AOX cDNA in a modified P-element vector under the
control of a GAL4-dependent promoter and protected by insu-
lator elements (Figure 1A). Standard microinjection was used
to create a set of transgenic lines with different conditionally
expressible AOX insertions. To test whether constitutive AOX
expression was compatible with life in Drosophila, we crossed
transgenic lines hemizygous for GAL4-dependent AOXwith lines
carrying the ubiquitously expressing da-GAL4 driver, using the
scheme of Figure 1B. Flies of all four phenotypic classes eclosed
in approximately equal numbers, using each of three different
AOX transgenic lines (F6, F17, and F24). We confirmed AOX
transgene expression at the RNA level bymeans of in situ hybrid-
ization (Figure 2A) and quantitative RT-PCR (Figures 2B and 2C)
and at the protein level by western blotting (Figures 2D and S1B)
and whole-mount immunocytochemistry of larvae (Figure S1C).
AOX transgene expression was generally higher in males than
females (Figures 2B and 2C), and the expressed protein was
highly enriched in mitochondria (Figures 2D and S1C). GAL4-
dependent AOX expression was 300–1000 times greater than
without induction and was comparable with that of the highly
expressed reference gene RpL32 (or GAPDH), used as an
internal standard in all assays. Similar expression levels were
obtained when driven by either of two ubiquitous GAL4 drivers
(da-GAL4 or Act5C-GAL4), and graded expression at larval
stage L3 was obtained using the drug-inducible tub-GS driver
and different concentrations of the inducing drug RU486.
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AOX Expression Complements OXPHOS Defects in FliesFigure 2. AOX Can Be Ubiquitously Expressed in Drosophila
(A) Whole-mount in situ hybridization to AOX-expressing and nonexpressing embryos, probed for AOX sense and antisense transcripts as indicated (‘‘sense’’
probe means labeled RNA of the antisense strand and vice versa). The different classes of embryos were obtained by crossing homozygous AOX transgenic
females either with wild-type males or with homozygous da-GAL4 driver males.
(B andC) Q-RT-PCRof AOXmRNA relative toRpL32mRNA, fromhemizygous AOX transgenic flies (line F6, L3 larvae, adult males and females of different ages as
shown) combined with different GAL4 drivers and growth temperatures or with the tub-GS driver in presence of different concentrations of RU486 throughout
development. Genotypes are indicated here and in other figures as follows. AOX denotes presence of a P{UAS-AOX} transgene from line F6, if no subscript indi-
cates otherwise. Numbers 2 and 3 denote the corresponding wild-type chromosomes. GAL4 driver transgenes are denoted as da-GAL4, etc. Wild-type flies are
w1118, the genetic background used for all the transgenic lines. AOXRNAwasundetectable byQ-RT-PCR in lines not carrying theAOX transgene.Means are ±SD.
(D) Western blot of protein extracts (30 mg) from subcellular fractions and flies of sex and genotype indicated, probed with anti-AOX and anti-porin antibodies.
Subpanel a: mitochondrial protein extracts from AOX-expressing flies and nonexpressing controls. Subpanels b and c: cytosolic (cyt), mitochondrial (mt), and
crude nuclear (nuc) fractions. Subpanel d: total and mitochondrial extracts, all from AOX-expressing (AOXF6 / 2 ; da-GAL4 / 3) flies.Ubiquitously AOX-expressing flies exhibited a very slight (#0.5
days) but statistically significant developmental delay (Figure 3A),
although this may be due solely to the burden of transgene
expression, since flies expressing GFP under the same condi-
tions also showed a slight delay.
AOX-expressing adults of both sexes were fertile and, when
mated to wild-type flies, produced healthy offspring in normal
numbers. AOX-expressing flies of both sexes showed a slightly
exaggerated weight loss as young adults compared with nonex-
pressers or with flies expressing GFP (Figure 3B).
AOX Supports KCN-Resistant Substrate Oxidation
To test whether AOX expression in Drosophila can contribute
to electron flow and thus bypass complexes III and IV, wemeasured oxygen consumption of suspensions of Drosophila
mitochondria in the presence of various substrate/inhibitor
combinations. In preliminary experiments, mitochondria from
AOX-expressing progeny of three separate AOX transgenic lines
supported a substantial cyanide-resistant substrate oxidation
(up to 50% of uninhibited levels) when supplied with pyruvate
plus succinate (data not shown). To minimize background
effects, we backcrossed the AOX transgene from the three
transgenic lines, as well as the da-GAL4 driver, over six genera-
tions into a reference wild-type background (Dahomey w)
and analyzed mitochondrial substrate oxidation using a
standard pyruvate-plus-proline substrate cocktail (Figures 4
and S2). The respiratory control index was unchanged by AOX
expression. However, after cyanide addition, mitochondriaCell Metabolism 9, 449–460, May 6, 2009 ª2009 Elsevier Inc. 451
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AOX Expression Complements OXPHOS Defects in FliesFigure 3. AOX Expression in Drosophila Is Benign
(A) Eclosion day of flies of the sex and genotype shown. Means ± SD analyzed by one-way ANOVA (Holm-Sidak); p < 0.001 for pairwise comparisons as indicated
by asterisk.GFP denotes the presence of a P{UAS-GFP} transgene, on chromosome 2 in this experiment and in other figures, except where indicated. Flies were
progeny fromwild-type, homozygous AOXF6, orGFP control transgenic femalesmated either with wild-type males (respectively giving wild-type, AOX, andGFP-
nonexpressing progeny) or with homozygous da-GAL4 driver males (giving AOX and GFP expressers and ‘‘driver-only’’ controls). The developmental delay
produced by GFP expression was similar to that produced by AOX, although in this case not statistically significant (p = 0.42).
(B) Weight loss profiles (percent wet weight at eclosion) in young adult flies of the sex and genotype shown, obtained as in (A).GFP-nonexpressing flies (GFP / 2;
3 / 3) gave weight loss profiles indistinguishable from controls, but for clarity, these are not shown in the figure. Means are ± SD.from AOX-expressing flies typically maintained 10%–20% of the
uninhibited state 3 oxygen consumption. Subsequent addition of
propyl gallate (data not shown) or salicylhydroxamic acid
(SHAM) (Figure 4A), two well-characterized inhibitors of alterna-
tive oxidases, abolished the residual cyanide-resistant oxida-
tion. However, if SHAM was added first, it had no effect
(Figure S2H), indicating that AOX did not contribute appreciably
to electron flow under uninhibited conditions. In one transgenic
line analyzed in greater detail (F6), the proportion of cyanide-
resistant oxidation was increased when measured at 29C
(Figure 4C). In aging flies (at 50% of mean life span), where state
3 substrate oxidation was diminished, the cyanide-resistant
proportion was maintained (Figure 4C). On sn-glycerol-3-phos-
phate, a substrate that feeds electrons directly to complex III,
AOX-expressing flies also manifested cyanide-resistant oxida-
tion (Figure S2E). No cyanide-resistant substrate oxidation could
be detected in mitochondrial suspensions from flies carrying the
da-GAL4 driver but not AOX, nor those expressing a control
transgene, GFP (Figures 4C and S2F). OXPHOS enzyme activi-
ties in AOX-expressing flies were indistinguishable from those
of nonexpressers (Figure 4D), including cytochrome c oxidase
(complex IV). Note that this is expected, since AOX is a ubiquinol
oxidase, not a cytochrome c oxidase.
AOX Confers OXPHOS Toxin Resistance In Vivo
To determine whether AOX can function in vivo to bypass the
cytochrome chain under OXPHOS stress conditions, we tested452 Cell Metabolism 9, 449–460, May 6, 2009 ª2009 Elsevier Inc.flies for resistance to cyanide and antimycin: inhibitors, respec-
tively, of complexes IV and III. Because of the volatility of HCN,
we established an assay to test the short-term toxicity of cyanide
to adult flies by placing them inside plugged vials containing
agarose impregnated with 10 mM KCN. Control flies were inca-
pacitated within 5min of such treatment, whereas AOX-express-
ing flies remained active during 20–30 min of cyanide exposure
(Figure 5A). All of the AOX-expressing flies exposed to KCN
recovered from paralysis overnight, whereas only 1%–2% of
nonexpressing flies did so. Resistance to antimycin was tested
by addition of the drug at various concentrations to fly food.
Control eggs laid on 30 mg/ml antimycin failed to develop, and
those laid on 10 mg/ml antimycin developed only to first instar
(L1) larvae, whereas AOX-expresser eggs laid on antimycin-
containing medium developed to adults in substantial numbers
(Figures 5B and S2J), albeit with a considerable developmental
delay (3–5 days at 25C). Adult AOX-expressing flies were also
resistant to antimycin at 30 or 100 mg/ml, and someeven survived
for 3 days at the highest concentration (Figure 5C).Control flies all
succumbed to the toxin, even at the lower dose, within 2 days.
AOX Complements Partial Knockdown of COX
In Drosophila, complete functional loss of cytochrome oxidase
(COX), e.g., via homozygosity for a null mutation of cyclope
encoding the COXVIc structural subunit of complex IV, is lethal.
AOX expression was unable to complement this complete loss
of function (data not shown). However, it did rescue the lethality
Cell Metabolism
AOX Expression Complements OXPHOS Defects in FliesFigure 4. Mitochondria from AOX-Expressing Flies Exhibit Cyanide-Resistant Substrate Oxidation
(A–D) Representative polarographic traces showing rates of oxygen consumption (A and B) plus compiled polarographic data (C) and respiratory chain complex
activities (D) from flies of the sex, age, growth/assay temperature, and genotype indicated. Genotypes abbreviated as elsewhere; transgenes in all cases hemi-
zygous. The traces shown in (A) and (B) are for males of transgenic line F6, with or without the da-GAL4 driver. The data of (C), in each casemean values ± SEM of
at least four independent measurements, are abstracted from those of Figure S2. Substrate mix was 5 mM pyruvate plus 5 mM proline (pyr + pro) in all cases
shown. Asterisks indicate data classes significantly different from corresponding wild-type values (ANOVA, p < 0.001). The data in (D) are from flies derived
as in Figure 2, in each case showing mean values ± SD of at least four independent measurements, normalized against citrate synthase (CS) activity.caused by partial knockdown of COX, effected using RNAi tech-
nology against either cyclope or the complex IV assembly factor
Surf1. We combined GAL4-dependent dsRNA lines for each of
these genes with GAL4-dependent AOX, plus a suitable driver,
thus simultaneously knocking down cyclope and expressing
AOX. Using the ubiquitous da-GAL4 driver, AOX was able to
rescue the semilethality of cyclope knockdown (Figures 6A,
6B, and S3A–S3E). The clearest result was obtained by culturing
the flies at 18C, combined with a 2 day heat shock at 30C
during larval stage L3 (Figure 6A), conditions under which very
few flies knocked down for cyclope eclosed, unless AOX was
coexpressed. At 25C (Figures S3A and S3E), AOX abrogated
the developmental delay and small size of the eclosing progeny
knocked down for cyclope. Expression of an inert transgene,
GFP, failed to effect rescue (Figure S3C). Mitochondrial COX
activity from AOX-expressing flies knocked down for cyclope
was less than half that from AOX-expressing control flies
(Figures 6B and S3D). In contrast, AOX expression by the
same strategy was unable to complement the lethality of knock-down of CG3731, which encodes a protein with a dual function
as a subunit of OXPHOS complex III and subunit b of the mito-
chondrial matrix processing peptidase. The rescue of cyclope
knockdown by AOX is thus, by all these criteria, specific.
In the case of Surf1 knockdown (Zordan et al., 2006), we
were able to demonstrate rescue using the inducible tub-GS
driver in combination with different doses of the inducing
drug RU486 (Figures 6C and 6D). At the highest doses, AOX
was unable to rescue lethality, whereas at low doses, knock-
down was insufficient to produce complete lethality, even in
control flies. However, at intermediate doses, where Surf1
knockdown alone was still lethal or semilethal, concomitant
AOX expression under the control of the same driver rescued
the lethality. The extent of Surf1 mRNA knockdown, as
measured by Q-RT-PCR, was similar in AOX-expressing and
nonexpressing flies cultured at the discriminating drug concen-
tration of 0.2 mM (Figure S3F). Importantly, expression of an
inert transgene, GFP, under identical conditions failed to rescue
the lethality (Figure 6D).Cell Metabolism 9, 449–460, May 6, 2009 ª2009 Elsevier Inc. 453
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AOX Expression Complements OXPHOS Defects in FliesFigure 5. AOX-Expressing Flies Are Resistant to Cyanide and Antimycin
(A and B) Flies of genotypes indicated (nomenclature as in Figures 2 and 3; transgene and driver hemizygous where present), exposed to drugs as described in
Experimental Procedures. Exposure was to 10 mM KCN. Mean survival time ± SD for batches of >100 of sex and genotype is indicated (A). Development on
antimycin is shown in (B); food vials at 5 days postfertilization, containing antimycin at the concentrations indicated, and larvae of genotypes as shown. On anti-
mycin-containing food, when AOX-expressing flies were at larval stage L3, wild-type flies failed to survive embryogenesis (at 30 mg/ml) or arrested in early larval
stages (at 10 mg/ml). AOX-expressing progeny survived to eclosion, but with a 3–5 day developmental delay. For quantitation, see Figure S2J.
(C) Exposure of adult flies to antimycin-containing medium, as indicated. Data are from 12 replicate vials of each genotype and drug concentration shown, con-
taining initially 15 males or virgin females. Data (means ± SD) from the two sexes were statistically indistinguishable, so are here pooled.AOX Complements a Parkinson’s Disease Model
Reasoning that AOX expression, by helping to maintain the
respiratory chain in the oxidized state, may mitigate ROS
production resulting from transient OXPHOS interruption, we
investigated its effects in a Drosophila model of Parkinson’s
disease associatedwith defects in ROS handling, i.e., themutant
dj-1b. The human homolog (DJ1) has been identified as the
disease gene in some cases of familial Parkinson’s disease,
and the fly mutant exhibits progressive locomotor decline (Park
et al., 2005).
To test for complementation of dj-1b, wemeasured locomotor
ability of wild-type and mutant flies over a period of 4 weeks
posteclosion as well as of dj-1b flies hemizygous for AOX, plus
or minus each of two GAL4 drivers, nrv2-GAL4 (nervous-
system-specific) and ubiquitous Act5C-GAL4 (Figures 7A and
S4A). We confirmed the previously reported locomotor defect454 Cell Metabolism 9, 449–460, May 6, 2009 ª2009 Elsevier Inc.of dj-1b and found that the presence of the AOX transgene,
even without a driver, conferred a partial rescue. Rescue was
substantially enhanced by ubiquitous or nervous-system-
directed AOX expression. In AOX-expressing males, the dj-1b
locomotor defect was almost completely abolished. The drivers
alone conferred no such rescue.
To determine whether rescue of dj-1b was related to allevia-
tion of oxidative stress, we measured ROS production in mito-
chondrial suspensions from flies aged 20–22 days, a time point
at which AOX-nonexpressing dj-1b flies manifested a substan-
tial locomotor defect. Mitochondria from flies of the various
genotypes studied gave state 3 substrate oxidation and respi-
ratory control index similar to those of aging AOX-expressing
and wild-type flies studied earlier (Figure S4B). However,
ROS production, measured as released hydrogen peroxide,
was significantly higher in mitochondria from dj-1b mutant flies
Cell Metabolism
AOX Expression Complements OXPHOS Defects in FliesFigure 6. AOX Rescues Semilethality Due to COX Deficiency
(A) Proportion (mean percentages ± SD; three replicate experiments) of progeny of each genotype indicated, eclosing from cross between da-GAL4 homozygous
females andmales of genotype cype-KD /CyO ;AOXF24 /Sb. Nomenclature is as in Figure 2; cype-KD encodesGAL4-dependent cyclope-directed dsRNA (Dietzl
et al., 2007). Sb and CyOmarkers enable the progeny classes to be distinguished. Flies were cultured at 18Cwith a 2 day heat shock at 30C during larval stage
L3 (see also Figures S3A and S3B). In parallel experiments, using CG3731-KD in place of cype-KD, flies equivalent to only the first two progeny classes eclosed
(data not shown). CG3731 serves a dual function as core subunit 1 of OXPHOS complex III and the b subunit of the mitochondrial matrix processing peptidase,
hence its knockdown has pleiotropic effects not rescued by AOX.
(B) COX-specific activity in AOX-expressing flies from the cross, either with or without concomitant cype knockdown. For same data normalized against citrate
synthase activity, see Figure S3D. Means are ± SD.
(C and D) Crosses showing survival of flies hemizygous for Surf1-KD (encoding GAL4-dependent Surf1-directed dsRNA) and tub-GS transgenes, each on
chromosome 3, with or without hemizygous AOXF6 or GFP as an additional GAL4-dependent transgene on chromosome 2, cultured at different doses of the
inducing drug RU486. Image of actual vials is shown in (C), in which AOX-expressing flies consistently reach further in development than nontransgenic flies
at any given drug dose. Percentage of pupae eclosing from parallel crosses, of the genotypes indicated, is also shown (D). Data from three different experiments
superimposed.than from wild-type flies of a given sex (Figure 7B). The pres-
ence of the unexpressed AOX transgene alone did not signifi-
cantly mitigate this excess ROS production, but ubiquitous
AOX expression decreased ROS production to wild-type levels
(Figure 7B).
DISCUSSION
We previously demonstrated that the expression of Ciona intes-
tinalis AOX can support cyanide-independent respiration and
complement OXPHOS inhibition in cultured human cells (Hak-kaart et al., 2006). The present work demonstrates that this
applies also to a whole-organism model, Drosophila, in vivo.
AOX Expression Is Benign
Ubiquitous AOX expression in Drosophila at the level of a typical
abundant mRNA appears to be benign. The protein is stable, is
correctly targeted to mitochondria, and confers substantial and
significant cyanide resistance to mitochondrial substrate oxida-
tion in vitro. As in human cells, it appears to be enzymatically
inert in the absence of an OXPHOS inhibitor (Figure S2H) and
thus should not contribute significantly to electron flow underCell Metabolism 9, 449–460, May 6, 2009 ª2009 Elsevier Inc. 455
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AOX Expression Complements OXPHOS Defects in FliesFigure 7. AOX Expression Rescues the dj-1b Mutant Phenotype
(A) Locomotor (climbing) assay, flies of sex and genotypes indicated, in the (w1118) background; nomenclature as in Figure 2. The AOX transgene, where present,
was derived from transgenic line F6 (insertion on chromosome 2). dj-1b is on chromosome 3, whereas the nrv2-GAL4 and Act5C-GAL4 drivers are carried on
chromosome 2. Each set of bars (left to right) corresponds with a series of assays at 2, 7, 14, 21, and 28 days posteclosion. Means are ± SD from at least
two and usually three or four replicate experiments, using 12–18 vials of ten flies of each sex and genotype.
(B) ROS (H2O2) production in mitochondria from flies of the sex and genotypes indicated. Plotted data are means ± SEM of at least five biological replicates.
Asterisks denote data classes statistically different from other data classes, based on one-way ANOVA (Newman-Keuls test); males and females analyzed
separately.normal physiological conditions nor diminish ATP production by
a substantial amount. Consistent with this, it had only a minimal
effect on development (Figure 3A), with a slight exaggeration of
the weight loss experienced by young adult flies (Figure 3B),
suggestive of only a small drop in the overall efficiency of catab-
olism. A slight impairment thereof might nevertheless be suffi-
cient to account for the evolutionary loss of AOX in both verte-
brates and arthropods, organisms where maximal muscle-force
generation, dependent on aerobic ATP supply, may be needed
to escape predators or catch prey. Among metazoans, AOX
genes have so far been found only in phyla composed of slow-
moving or sessile organisms. AOX-expressing flies were also
fertile. Although pUAST-derived transgenes are not expressed
in the female germline (Rørth, 1998), AOX expression clearly
does not compromise any somatic functions required for fertility.
AOX Rescues Lethality of Partial COX Deficiency
Resistance to antimycin and cyanide indicates that AOX can
support at least a portion of the electron flow to oxygen when
the cytochrome chain is inhibited in vivo. Cyanide is a wide-
spectrum reversible inhibitor of oxygen-binding hemoproteins,
including hemoglobin as well as COX. Although a globin
homolog is present in insects (Hankeln et al., 2002), it is thought
not to be involved in primary electron transport. The fact that
AOX-expressing flies can develop on antimycin-containing
medium indicates that proton pumping at complex I, plus
some residual activity of the cytochrome chain, is sufficient to
maintain ATP production at a rate that supports life. Importantly,
although AOX is not itself proton pumping, it should nevertheless456 Cell Metabolism 9, 449–460, May 6, 2009 ª2009 Elsevier Inc.facilitate increased ATP production (at complex I or through
substrate-level phosphorylation) under conditions of OXPHOS
inhibition. It should also restore redox homeostasis and meta-
bolic flux. AOX-expressing flies grown on antimycin-containing
medium nevertheless showed a considerable developmental
delay, a phenotype shared with mutants affecting OXPHOS,
such as technical knockout (Toivonen et al., 2001), stress-sensi-
tive B (Zhang et al., 1999), and knockdown (Fergestad et al.,
2006). This delay may therefore be interpreted as a signature
of bioenergy limitation during development.
The complete elimination of COX (e.g., via null alleles of
cyclope, or effected by Surf1 knockdown at high concentrations
of RU486) is lethal even in the presence of AOX. This implies that
proton pumping through complex I alone, maintained by the
action of AOX handling downstream electron flow, nevertheless
supplies insufficient ATP to maintain life. Note, however, that
assembled complex IV may be required for efficient assembly
or stabilization of the other OXPHOS complexes (Boekema
and Braun, 2007), so the COX-deficient phenotype might in
reality be pleiotropic. Partial knockdown of cyclope, which
diminished COX activity by more than 50% in adult flies, was
rescued by AOX, which gives an indication of the degree of
COX defect that could potentially be compensated therapeuti-
cally. Similarly, AOX was able to rescue the pupal lethality of
partial Surf1 knockdown. The effect cannot be attributed to
competition between the GAL4-dependent promoters, since
the amount of knockdown was unaffected by coexpression of
AOX (Figure S3F), and an inert GAL4-dependent transgene
(GFP) produced no rescue (Figures 6D and S3G).
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but its null phenotype varies greatly between organisms.
Suppressor analysis in yeast (Barrientos et al., 2002) implicated
the Surf1 homolog in an early step of complex IV assembly.
However, the interference with respiration is greater than can
be accounted for by complex IV deficiency alone (Mashkevich
et al., 1997), suggesting a more global role in organization of
the respiratory membrane or coupling between complexes III
and IV. Loss of SURF1 function in humans causes COX-deficient
Leigh Syndrome (Zhu et al., 1998; Tiranti et al., 1998; Yao and
Shoubridge, 1999), but in the mouse, functional ablation of
Surf1, while provoking a decreased COX activity (Dell’agnello
et al., 2007), has virtually no physiological phenotype, supporting
the notion that Surf1 may have additional roles. In Drosophila,
when knockdown was targeted specifically to the nervous
system, impaired larval locomotion and adult optomotor
responses were found, even though the decrease in COX activity
in the brain was modest (Zordan et al., 2006). Although SURF1/
SHY1mutations in humans and yeast are recessive, the amount
of Surf1 knockdown required to produce lethality in flies is only
65% at the RNA level (Zordan et al., 2006). In the present study,
a knockdown of 40%–50% at the RNA level was sufficient to
cause semilethality, although knockdown may be more efficient
at the protein level (Zordan et al., 2006). It will be interesting to
determine the exact degree of Surf1 knockdown that AOX can
compensate and the concomitant effects on OXPHOS biochem-
istry. To this end, transgenic flies constitutively expressing AOX
without the need for a driver will be a useful tool.
AOX and Parkinson’s Disease
AOX expression was able to complement also the phenotype of
a Drosophila strain carrying a mutation in a homolog of a human
Parkinson’s disease gene (DJ1). Although the pathological
mechanism of DJ1 mutations is poorly understood, there is
a general consensus that DJ1 deficiency entrains increased
susceptibility to mitochondrial oxidative stress, particularly in
the vulnerable dopaminergic neurons of the substantia nigra
(Beal, 2007; Tan and Skipper, 2007). DJ1 has been postulated
as both a sensor and a scavenger of ROS (Mitsumoto and Naka-
gawa, 2001; Taira et al., 2004; Canet-Aviles et al., 2004), and Dj1
null mice are sensitive to oxidative stress (Kim et al., 2005), as are
Drosophila mutants in either dj-1b or DJ-1a (Park et al., 2005;
Menzies et al., 2005; Yang et al., 2005; Lavara-Culebras and
Paricio, 2007). DJ1 has been suggested to function as a peroxir-
edoxin (Andres-Mateos et al., 2007) or as a chaperone (Zhou
et al., 2006) for alpha-synuclein, whose aggregation it prevents
(Batelli et al., 2008). It also protects against oxidative damage
in cerebral ischemia (Aleyasin et al., 2007). AOX rescue of
dj-1b is consistent with the idea that ROS overproduction
caused by mitochondrial dysfunction is a common underlying
feature of Parkinson’s disease etiology (Beal, 2007; Tan and
Skipper, 2007; Dimauro and Schon, 2008). Transient interrup-
tions of electron flow may result in episodic bursts of excess
ROS production. The AOX bypass would prevent such distur-
bances, decreasing net ROS production to levels that are no
longer pathological, despite the failure of the detoxification
system provided by dj-1b. A second possibility would be that
AOX eliminates mitochondrial ROS directly, e.g., using semiqui-
none radicals as substrate. AOX is induced in Euglena, alongwith many antioxidant enzymes, by treatment with Cd2+ (Cas-
tro-Guerrero et al., 2008), a pro-oxidant (Watanabe et al., 2003),
and its overexpression in plants protects from cold-induced
oxidative stress (Sugie et al., 2006).
Low-level AOX expression in the absence of driver gave a tran-
sient locomotor rescue (Figures 7A and S4), even though its
effects on mitochondrial ROS production were modest. AOX
expression driven by nrv2-GAL4, which is highly restricted to
the nervous system (Sun et al., 1999), completely rescued the
locomotor defect. AOX expression directed only by the pUAST
promoter in some specific but critical cells of the nervous
system may thus be sufficient for rescue, even though, when
ROS production is assayed in extracts prepared from the whole
fly, the effect is diluted. Alternatively, since the beneficial effects
of low-level AOX expression were seen only in young flies,
effects on ROS production might be detectable only early in
development.
Conclusion: The Therapeutic Potential of AOX
We showed previously that AOX can alleviate many deleterious
consequences of OXPHOS dysfunction in cultured cells (Hak-
kaart et al., 2006). Here, we demonstrate that its expression is
well tolerated in a whole organism lacking endogenous AOX,
alleviating the effects of toxins or mutations affecting the cyto-
chrome chain. Two suchmutations representDrosophilamodels
of different classes of human OXPHOS disease, namely COX-
deficient Leigh Syndrome (Surf1 knockdown) and familial Parkin-
son’s disease (dj-1b). The next step in testing whether AOX could
have therapeutic utility would be to express it in mammalian
models. The findings with Drosophila suggest that it could be
of benefit in a wide spectrum of OXPHOS disorders. However,
many technical obstacles will need to be overcome to make
this a feasible therapeutic strategy, such as optimizing the
enzyme for physiological temperature and oxygen levels and
addressing its possible antigenicity.
EXPERIMENTAL PROCEDURES
Drosophila Stocks and Maintenance
Wild-type, w1118 mutant, standard balancer, driver, and RNAi lines were ob-
tained from stock centers, with other lines derived or sourced as indicated in
Table S1, which also gives details of all genotypes. Flies were maintained in
standard medium with supplements (see Supplemental Data). For testing of
resistance to antimycin, the drug (Sigma) was added to fly food at different
concentrations. For testing of resistance to cyanide, 1 day old adult flies
were placed inside plugged vials of 1% agarose containing 10 mM KCN,
50 mM Tris-HCl (pH 7.5) inside a fume hood at room temperature. After flies
stopped moving, they were transferred to empty vials to check for recovery
overnight. For induction of expression using the tub-GS driver, flies hemizy-
gous for both the driver and the GAL4-dependent transgene(s) of interest
were cultured in the presence of appropriate doses of RU486 (Mifepristone;
Sigma), as indicated in figure legends.
Construction of AOX Transgenic Drosophila Lines
The C. intestinalis AOX cDNA, originally cloned in mammalian expression
vector pCDNA5/FRT/TO (Hakkaart et al., 2006), was excised and recloned
into a modified version of pGREEN-H-Pelican (Barolo et al., 2000) (Drosophila
Genomics Resource Center; Bloomington, IN), placing it under the control of
GAL4 supplied in trans (for full details, see Figure S1A). All restriction diges-
tions were carried out under manufacturer’s recommended conditions (New
England Biolabs; Fermentas). The myc-tagged AOX cDNA was similarly
recloned from the original mammalian expression vector (Hakkaart et al.,Cell Metabolism 9, 449–460, May 6, 2009 ª2009 Elsevier Inc. 457
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absence of mutations. Following microinjection into w1118 recipient embryos
(VANEDIS Drosophila Injection Service; Oslo), transgenic progeny were estab-
lished as independent lines in the w1118 background. Insertion sites were
determined by inverse PCR (Toivonen et al., 2003) (see Supplemental Data
for further details, including insertion sites). Selected lines retained were main-
tained as hemizygotes using the eye-color marker and appropriate balancers
and used to generate homozygotes as needed.
Isolation of Mitochondria
Mitochondria were prepared essentially as described by Miwa et al. (2003),
from batches of 150–200 flies ground in 0.5 ml isolation medium, with final re-
suspension in 50 ml isolation medium without BSA. Protein concentrations
were determined using the Bradford assay (Bradford, 1976). For full details
of subcellular fractionation used for western blotting, see Supplemental Data.
Polarography
Mitochondrial substrate oxidation rates were measured by polarography using
a Clark type oxygen electrode (Hansatech Instruments; Norfolk, UK) in a final
volume of 0.5 ml at 25C. Mitochondria (between 0.25 and 0.5 mg/ml) were
incubated in incubation buffer (120 mM KCl, 5 mM KH2PO4, 3 mM HEPES,
1 mM EGTA, 1 mM MgCl2, 0.2% BSA [pH 7.2]) supplemented with either
20 mM sn-glycerol-3-phosphate (plus 5 mM rotenone; Sigma) or a mixture of
5mMsodium pyruvate and 5mMproline as substrate, followed by the addition
of 1 mM ADP, with subsequent addition of 100 mM KCN or 10 mM SHAM
(Sigma) to test the effect of AOX on substrate oxidation.
Enzymatic Analysis
The activities of OXPHOS complexes I + III and II + III were measured as
described previously (Ferna´ndez-Ayala et al., 2005). Citrate synthase activity
was determined by the reduction of dithio-bis-nitrobenzoic acid (DTNB) fol-
lowed at 412 nm (extinction coefficient = 21,000 M1/cm1) in a reaction con-
taining 100 mM Tris-HCl, 2.5 mM EDTA, 37 mM acetyl-CoA, 75 mMDTNB, and
300 mM oxaloacetate (pH 8.0). COX activity was measured in 40 mM sodium
phosphate buffer (pH 7.5) by following the disappearance of thiosulfite-
reduced cytochrome c (initially 25 mM) at 550 nm (extinction coefficient =
27,800 M1/cm1). Specific activity was determined by subtracting the rate
in the presence of 2 mM KCN from the rate without the inhibitor.
Measurement of Mitochondrial ROS Production
Mitochondrial free radical production was determined by measuring the
generation of hydrogen peroxide in solution in the presence of superoxide dis-
mutase, as described previously (Sanz and Barja, 2006), and adapted to flies
(Miwa et al., 2003). For further details, see Supplemental Data. Known
amounts of H2O2 generated in parallel by glucose oxidase with glucose as
substrate were used as standards. All experiments were repeated in the
absence of substrate, and background fluorescence changes were sub-
tracted.
RNA Extraction and Quantitation
For expression analysis, homozygous AOX transgenic line F6 females were
crossed either to males homozygous for the da-GAL4 or tub-GS driver or to
males hemizygous for the Act5C-GAL4 driver balanced against CyO. Total
RNA was extracted using the Trizol method from 100 mg of adult flies or L3
larvae anesthetized on ice and then frozen at 80C, followed by treatment
with RNase-free DNaseI (for full details, see Supplemental Data). Quantitative
RT-PCRwas carried out under standard conditions using hybridization probes
specific for AOX, RpL32, and GAPDH (Tib-MolBiol; Berlin) on a Roche Diag-
nostics LightCycler 1.5 (for full details, see Supplemental Data).
In Situ Hybridization
Whole-mount in situ hybridization was performed essentially as described by
Ferna´ndez-Moreno et al. (2007), with minor modifications as indicated in the
Supplemental Data.
Protein Extraction and Western Blotting
Protein extraction and western blotting used standard reagents and proce-
dures as detailed in Supplemental Data. Custom-manufactured anti-AOX458 Cell Metabolism 9, 449–460, May 6, 2009 ª2009 Elsevier Inc.antibody (rabbit polyclonal) was supplied by 21st Century Biochemicals
(Marlboro, MA).
Behavioral Analysis
Locomotor activity was determined in two ways. Climbing ability was assayed
using a modified version of the procedure of Cha et al. (2005), as detailed fully
in Supplemental Data. The second method used a combined bang-sensitivity/
climbing assay. Aliquots of 20 adult female flies aged 20–22 days were vor-
texed at the maximum setting for 30 s, after which the percentage of flies
climbing 7 cm in 15 s was recorded.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures,
Supplemental References, two tables, and four figures and can be
found online at http://www.cell.com/cell-metabolism/supplemental/S1550-
4131(09)00064-3.
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